Lumeris and STCC Join Forces to Enhance Telehealth Triage with Tom™
In a transformative move for telehealth, Lumeris, a key player in healthcare technology, has teamed up with Schmitt-Thompson Clinical Content (STCC), a leader in telehealth triage guidelines, to enhance Lumeris' AI-powered symptom-checking tool, Tom™. This comprehensive collaboration aims to elevate patient care by integrating trusted clinical guidance within the Tom™ platform.
The partnership emphasizes the integration of STCC’s evidence-based triage content into Tom™, enriching it with robust clinical foundations. This upgrade is crucial as it targets the inefficiencies in patient navigation between primary care visits, especially for individuals managing chronic conditions or complex health needs.
Patients often face health-related inquiries or new symptoms that arise between appointments. Without immediate guidance, they might delay seeking care or head to unnecessary high-acuity facilities. The Tom™ symptom-checking capability acts as a frontline resource, allowing patients to report symptoms, ask questions, and interact in a conversational manner, which can lead to quicker identification of those who may need further clinical intervention.
Dr. David Carmouche, Chief Medical and Commercial Officer at Lumeris, stressed the importance of timely access to support for high-risk populations. He noted that the integration of STCC's clinical guidance is vital for delivering consistent symptom assessments and enhancing clinical workflows. This collaborative effort allows care teams to efficiently determine next steps for patient needs, which ultimately leads to safer and faster interventions.
After symptom-checking interactions, Tom™ generates structured summaries and prioritization advice, aiding care teams in swift evaluations and decisions on patient care actions. Notably, this function complements existing clinical workflows, providing a means to extend support in less traditional settings while still maintaining clinical integrity.
The primary aim is to advance Lumeris' vision for Tom™ as an indispensable part of the healthcare team—not as a replacement for human providers, but as a powerful assistant in the field. By merging AI-driven patient engagement with authoritative clinical content, the goal is to improve overall patient experience and ensure more proactive, coordinated care delivery.
STCC's commitment to leading with evidence-based decisions confirms its status as a trusted resource for telehealth guideline development, widely utilized by hospitals and insurance providers across North America. The integration within Tom™ is expected to foster consistency in patient care responses, establishing a standardized approach to symptom management.
Patty Maynard, Chief Operating Officer at STCC, expressed excitement about the partnership, emphasizing how it enables healthcare organizations to deliver enhanced symptom-checking experiences combining modern conversational technology with time-tested clinical insights.
As healthcare evolves, the synergy between technology companies like Lumeris and clinical guidance providers such as STCC represents a significant step forward in ensuring patients receive timely assistance, potentially revolutionizing the landscape of telehealth services. Both organizations are poised to leverage their strengths to further develop tools that can adapt to patient needs and enhance the quality of healthcare delivery.
In conclusion, the collaboration of Lumeris and STCC highlights a progressive shift towards integrating advanced technology and evidence-based practices to meet the growing demands of patients and healthcare providers alike. Together, they envision a future where technology plays a crucial role in bridging the gap between patients and effective health care, fostering a more responsive and interconnected healthcare environment.
The partnership emphasizes the integration of STCC’s evidence-based triage content into Tom™, enriching it with robust clinical foundations. This upgrade is crucial as it targets the inefficiencies in patient navigation between primary care visits, especially for individuals managing chronic conditions or complex health needs.
Patients often face health-related inquiries or new symptoms that arise between appointments. Without immediate guidance, they might delay seeking care or head to unnecessary high-acuity facilities. The Tom™ symptom-checking capability acts as a frontline resource, allowing patients to report symptoms, ask questions, and interact in a conversational manner, which can lead to quicker identification of those who may need further clinical intervention.
Dr. David Carmouche, Chief Medical and Commercial Officer at Lumeris, stressed the importance of timely access to support for high-risk populations. He noted that the integration of STCC's clinical guidance is vital for delivering consistent symptom assessments and enhancing clinical workflows. This collaborative effort allows care teams to efficiently determine next steps for patient needs, which ultimately leads to safer and faster interventions.
After symptom-checking interactions, Tom™ generates structured summaries and prioritization advice, aiding care teams in swift evaluations and decisions on patient care actions. Notably, this function complements existing clinical workflows, providing a means to extend support in less traditional settings while still maintaining clinical integrity.
The primary aim is to advance Lumeris' vision for Tom™ as an indispensable part of the healthcare team—not as a replacement for human providers, but as a powerful assistant in the field. By merging AI-driven patient engagement with authoritative clinical content, the goal is to improve overall patient experience and ensure more proactive, coordinated care delivery.
STCC's commitment to leading with evidence-based decisions confirms its status as a trusted resource for telehealth guideline development, widely utilized by hospitals and insurance providers across North America. The integration within Tom™ is expected to foster consistency in patient care responses, establishing a standardized approach to symptom management.
Patty Maynard, Chief Operating Officer at STCC, expressed excitement about the partnership, emphasizing how it enables healthcare organizations to deliver enhanced symptom-checking experiences combining modern conversational technology with time-tested clinical insights.
As healthcare evolves, the synergy between technology companies like Lumeris and clinical guidance providers such as STCC represents a significant step forward in ensuring patients receive timely assistance, potentially revolutionizing the landscape of telehealth services. Both organizations are poised to leverage their strengths to further develop tools that can adapt to patient needs and enhance the quality of healthcare delivery.
In conclusion, the collaboration of Lumeris and STCC highlights a progressive shift towards integrating advanced technology and evidence-based practices to meet the growing demands of patients and healthcare providers alike. Together, they envision a future where technology plays a crucial role in bridging the gap between patients and effective health care, fostering a more responsive and interconnected healthcare environment.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.